USP15 Enzyme: A New Target for Ovarian Cancer Treatment
Ovarian cancer is frequently diagnosed after the disease has already spread to other parts of the body, leaving patients with a five-year survival rate of under 30 percent, according to researchers at the University of Maryland, Baltimore County (UMBC). Standard therapies often inflict heavy damage on healthy cells alongside malignant cells. New research published September … Read more